| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to a compound of formula (I):and pharmaceutically acceptable salts, diastereoisomers and enantiomers thereof, wherein D is specified in a group consisting of,and, M is; Z is -O-; Ar is a 6-member aromatic ring system substituted by 0 to 4 Rgroups; and G isor; the other radical values are presented in cl.1 of the patent claim, as well as to using them for inhibiting protein tyrosine kinase inhibition.EFFECT: preparing the new compounds.14 cl, 33 tbl, 191 ex |
